about kinex

Kinex Pharmaceuticals - Buffalo NY Biotechnology Company

Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.

Our Company >>

clinical trials

Kinex Pharmaceuticals Clinical Trials

Kinex has numerous clinical oncology studies underway or in the planning stage.

Clinical Trials >>

News/Events

Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results from a Phase I Clinical Study (HM-OTE-103) with Oratecan® in Patients with Advanced Cancer Wednesday, October 15th, 2014

Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals announce today preliminary results from a Phase I Clinical Study of Oratecan – an oral

Kinex Completes Acquisition of QuaDPharma Tuesday, September 9th, 2014

• Adds GLP and cGMP Capabilities to Kinex Platform • Generates Opportunity to Execute Against Global Manufacturing Opportunities Kinex Pharmaceuticals Inc. today

News/Events >>